Business
Telescope Innovations Installs Korea's First Self-Driving Lab for Pharma R&D and Education
Rapid three-week deployment, onsite support from two-time Nobel Laureate, and deep Canada-Korea collaboration underscore accelerating commercial momentumHIGHLIGHTS Telescope Innovations' installation of Korea's first Self-Driving Lab for pharmaceutical research completed just three weeks after contract signing Project facilitated by collaboration with the Acceleration Consortium (AC) and supported on site by two-time Chemistry Nobel Laureate Prof. Barry Sharpless Successful SDL delivery...
About this update from Telescope Innovations Corp
[{"type":"text","content":"Rapid three-week deployment, onsite support from two-time Nobel Laureate, and deep Canada-Korea collaboration underscore accelerating commercial momentum","length":153,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"HIGHLIGHTS","length":10,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Telescope Innovations' installation of Korea's first Self-Driving Lab for pharmaceutical research completed just three weeks after contract signing","length":155,"tagName":"p"}]},{"val":[{"type":"text","content":"Project facilitated by collaboration with the Acceleration Consortium (AC) and supported on site by two-time Chemistry Nobel Laureate Prof. Barry Sharpless","length":155,"tagName":"p"}]},{"val":[{"type":"text","content":"Successful SDL delivery demonstrates Telescope's growing commercial momentum, positioning Telescope and the AC to expand SDL adoption across pharma, industrial chemistry, energy, and agriculture","length":198,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":508,"olType":false},{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 9, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") announces the successful installation of the first pharmaceutical Self-Driving Lab ("SDL") in South Korea, delivered to the Korean Pharmaceutical and Biopharmaceutical Manufacturers Association ("KPBMA") for its new AI-focused R&D training centre in Seoul. The installation, completed only three weeks after the purchase was finalized, highlights the Company's ability to deploy integrated robotic and analytical systems on ambitious timelines, enabled in part by the Acceleration Consortium ("AC"). Two-time Nobel Prize winner in Chemistry and Telescope Advisor, Prof. Barry Sharpless joined the team on site to mark the installation and discuss the future of chemistry R&D with KPBMA leadership.","length":969,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":305,"url":"https://media.zenfs.com/en/newsfile_64/dce1f804f0848d1b03e505b6c465a34c"},"resized":{"...